Table-1.

S. No	Type of magnetic nanoparticle	Application	Reference
1.	Fe doped Au NPs	Hyperthermia-based therapy	50(a)
2.	y-Fe2O3 Cobalt ferrite	Hyperthermia-based therapy	40(b), 47
3.	Fe3O4 Fe3O4-poly vinyl alcohol	Hyperthermia-based therapy	47(a)
4.	NiFe2O4	Hyperthermia-based therapy	48
5.	γ-Fe2O3	Hyperthermia-based therapy	22, 47(b)
7.	Fe3O4@Chitosan	Hyperthermia-based therapy	42(a)
8.	Fe3O4@Block copolymers	Hyperthermia-based therapy	62(b)
9.	Fe3O4-Dextran stabilized Fe3O4@Aminosilan	Hyperthermia-based therapy	62
10.	Ferrite-Dextran stabilized	Hyperthermia-based therapy	62, 63, 64
11.	Fe3O4-dextran (mono & bilayer) stabilized	Hyperthermia-based therapy	45
12.	Fe3O4-Lauric acid stabilized	Hyperthermia-based therapy	70
13.	Fe3O4-Lauric acid stabilized MnFe2O4-Lauric acid stabilized CoFe2O4-Lauric acid stabilized	Hyperthermia-based therapy	25(a)
14.	Fe@ biscarboxyl- terminated poly(ethylene glycol) (cPEG)	Hyperthermia-based therapy	82(a)
15.	γ-MnxFe2-xO3 coated Acrypol 934 polymer	Hyperthermia-based therapy	142
16.	FeCo@Au	Hyperthermia-based therapy	47(a), 56, 61
17.	Fe@MgO	Hyperthermia-based therapy	165
18.	Fe3O4@Si	Hyperthermia-based therapy	169
19.	Fe2O3@SiO2	Hyperthermia-based therapy	84
20.	FeNi@Au microdiscs	Hyperthermia-based therapy	130
21.	Fe@Fe3O4	Hyperthermia-based therapy	69
22.	La0 56(CaSr)0 22MnO3 @ SiO2	Hyperthermia-based therapy	168
23.	Fe3O4@Au	Hyperthermia-based therapy	131
24.	Magnetite cationic liposomes (MCL)	Hyperthermia-based therapy	11, 66, 67, 68, 71, 72, 78.
25.	Fe3O4-Lauric acid stabilized	Hyperthermia-based therapy	59,70
26.	Fe2O3@SiO2 bound LHRH	Hyperthermia-based therapy	84
27.	SPIONs bound fluorophore bimane	Hyperthermia-based Controlled drug delivery	85
28.	Porous Fe3/Fe/SiO2	Hyperthermia-based Controlled drug delivery	32,33
29.	Fe@SiO2	Hyperthermia-based Controlled drug delivery	93
30.	poly-(N-vinyl- 2- pyrrolidone) (PVP)- modified silica core @ iron oxide shell	Hyperthermia-based Controlled drug delivery	33
31.	Mg-Al layered double hydroxides (LDH) coated magnesium ferrite NPs	Hyperthermia-based Controlled drug delivery	138
32.	Yolk-shell type nanospheres with movable cores of Au, SiO2, Fe3O4.	Hyperthermia-based Controlled drug delivery	139
33.	γ-MnxFe2 xO3 coated Acrypol 934 polymer	Hyperthermia-based therapy and controlled drug delivery	142
34.	Fe3O4@lipid membrane (MCL, magnetite cationic liposome)	Hyperthermia-based therapy and controlled drug delivery	71
35.	Fe@Carbon nanoparticles bound polymer	Hyperthermia-based therapy and controlled drug delivery	136
36.	Co@Au@ poly(sodium styrene sulfonate)/poly(allylamine hydrochloride)	Hyperthermia-based therapy and controlled drug delivery	19
37.	SPIONs@ sensitive poly (N-isopropylacrylamide) hydrogels	Hyperthermia-based therapy and controlled drug delivery	86
38.	Fe@Fe3O4 loaded 4- tetracarboxy phenyl porphyrin	Hyperthermia-based therapy and controlled drug delivery	69
39.	Carboplatin-Fe@C-loaded chitosan	Hyperthermia-based therapy and controlled drug delivery	166
40.	Zinc doped iron oxide nanocrystals encapsulated mesoporous silica	Hyperthermia-based therapy and controlled drug delivery	100
41.	MCL loaded 4-S- Cysteaminylphenol	Hyperthermia-based therapy and controlled drug delivery	167